Table 3.
Rank | HC (n=4) | BT (n=14) | AT (n=5) | All (n=23) | ||||
---|---|---|---|---|---|---|---|---|
|
|
|
|
|||||
miRNA name | Stability value | miRNA name | Stability value | miRNA name | Stability value | miRNA name | Stability value | |
1 | cel-miR-39 | 0.042 | cel-miR-39 | 0.247 | miR-1228 | 0.101 | cel-miR-39 | 0.069 |
2 | miR-1228 | 0.234 | miR-1228 | 0.534 | cel-miR-39 | 0.266 | miR-1228 | 0.102 |
3 | miR-16 | 0.720 | miR-16 | 0.940 | miR-16 | 0.981 | miR-16 | 0.350 |
HC: Healthy controls, BT: Before therapy of CRC patients, AT: After therapy of CRC patients, CRC: Colorectal cancer